Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Enhertu
Pharma
US' China deal policy, WCLC, Legend CEO—Fierce Pharma Asia
Most drug licensing deals with China will be safe from rules being drafted by the U.S. Treasury Department, Reuters reports.
Angus Liu
Sep 18, 2026 10:20am
AZ, Daiichi's Enhertu nabs long-sought NHS blessing from NICE
Sep 16, 2026 7:30pm
Increased deaths shadow Enhertu’s first-line lung cancer data
Sep 13, 2026 7:00pm
AstraZeneca dual lung cancer wins softened by bispecific fail
Aug 17, 2026 10:56am
Daiichi Sankyo flags accounting error; shares tank
Jul 31, 2026 11:39am
Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia
May 22, 2026 8:53am
